Short answer
Pros: it is minimally invasive, recovery takes days rather than months, clinical trials show a good safety profile, and some patients with arthritis report less pain and better function. Cons: the evidence is still limited and mixed, part of the benefit may be a placebo effect, it is not FDA approved for orthopedic conditions, results are not guaranteed, and it is usually paid out of pocket.
This guide focuses on what most patients mean by stem cell therapy: injections of mesenchymal stem cells for joint, tendon or back pain. It brings together the benefits, the risks and the most common myths in one place, so you can weigh them before talking to any clinic, including ours.
Pros and cons at a glance
| Pros | Cons |
|---|---|
| Minimally invasive: an injection, not an operation | Evidence is still limited and of mixed quality |
| Short recovery, usually a few days of soreness | Part of the improvement may be a placebo or contextual effect |
| Good safety profile in clinical trials | Not FDA approved for knee, hip, back or shoulder pain |
| May reduce pain and improve function in knee osteoarthritis | Results vary and take weeks to months to appear |
| Can help some patients delay surgery | Usually not covered by insurance |
| Uses the body’s own repair mechanisms | Quality varies widely between clinics |
The pros, in detail
1. No surgery and a fast recovery
The cells are injected under local anesthesia, usually guided by ultrasound. Most patients walk out the same day and return to light activity within days, compared with months of rehabilitation after joint replacement.
2. A favorable safety record in trials
Pooled analyses of randomized trials of mesenchymal stem cells in osteoarthritis report mostly mild, temporary side effects such as pain and swelling at the injection site, without a signal of serious harm.
3. Improvement in pain and function for some conditions
A 2024 network meta-analysis of knee osteoarthritis trials found improvements in pain and function with mesenchymal stem cells from several sources. The strongest data are for the knee; for the hip, shoulder and tendons the evidence is earlier but encouraging.
4. A possible way to postpone surgery
For people with early or moderate arthritis who are not ready for a replacement, regenerative therapy can be one option to stay active longer. It does not replace surgery when the joint has collapsed.
The cons, in detail
1. The evidence is not settled
Studies are often small, use different cell types and doses, and follow patients for a short time. The NBA’s 2020 consensus on orthobiologics, written for elite athletes, concluded that these treatments appear safe but that high-quality evidence is still lacking.
2. Placebo and contextual effects are large
A 2025 meta-analysis of randomized trials in knee osteoarthritis found that a substantial share of the improvement after injections also appears in control groups. That does not mean the therapy does nothing, but it is a reason to be skeptical of dramatic before-and-after claims.
3. Regulatory status
The FDA has not approved any stem cell product for orthopedic conditions, and it warns consumers about clinics that market unapproved products. Treatment in Colombia is legal but, as we explain in Is Stem Cell Therapy Legal in Colombia?, legal is not the same as approved.
4. Cost and uncertainty
Treatment is usually paid out of pocket, often with travel. Because results vary, you should only proceed if you understand that improvement is likely for some patients but not guaranteed for anyone.
What are the risks?
Risks depend on the procedure, the cells and the clinic. With a qualified team and proper technique they are mostly mild:
- Common: pain, swelling or bruising at the injection or harvest site for a few days.
- Uncommon: a temporary flare of joint pain or inflammation.
- Rare but serious: infection, or reactions to contaminated or poorly processed products. The FDA has documented serious harm, including blindness, mainly from unregulated products and unsafe injection sites.
Most of the serious events reported come from clinics that skip screening, use unverified products or inject into risky areas. Choosing the clinic is part of managing the risk.
Five common myths
| Myth | What the evidence says |
|---|---|
| Stem cells regrow a worn-out joint | Studies show less pain and better function in some patients; reliable cartilage regrowth has not been proven. |
| It works for everyone | Results vary. Advanced bone-on-bone arthritis responds poorly. |
| It is an embryonic stem cell treatment | Clinics treating joint pain use adult (mesenchymal) cells, not embryonic cells. |
| One injection fixes the problem forever | Effects develop over months and rehabilitation is part of the result. |
| If it is offered abroad it must be unsafe | Safety depends on the clinic, the physician and the cells, not on the country. |
Who is a good candidate?
The best candidates usually have early or moderate arthritis, chronic tendon problems or partial tears, have already tried physiotherapy and medication, and have realistic expectations. People with end-stage arthritis, active infection or cancer are generally not candidates. A consultation should end with a clear yes or no; see what happens during a consultation.
Frequently asked questions
What are the main pros of stem cell therapy?
It is minimally invasive, recovery takes days, clinical trials show a good safety profile, and some patients with arthritis or tendon problems report less pain and better function, sometimes allowing them to delay surgery.
What are the main cons of stem cell therapy?
The evidence is still limited and mixed, placebo effects are large, it is not FDA approved for orthopedic conditions, results vary and take time, and it is usually paid out of pocket.
Does stem cell therapy actually work?
For knee osteoarthritis, meta-analyses show improvements in pain and function, but part of the effect is shared with placebo. It is a reasonable option for selected patients, not a guaranteed cure.
What are the risks of stem cell injections?
Most side effects are mild, such as pain and swelling for a few days. Serious complications like infection are rare and are mostly linked to unregulated products or poor technique.
Why is stem cell therapy controversial?
Because some clinics market it for many diseases without solid evidence, and because research on embryonic stem cells raised ethical debates. Treatments for joint pain use adult cells and are judged on clinical evidence.
References
- Efficacy and safety of mesenchymal stem cells from varied sources in knee osteoarthritis: systematic review and network meta-analysis (2024)
- Relative efficacy and safety of mesenchymal stem cells in osteoarthritis: systematic review and meta-analysis
- Contextual effects of mesenchymal stem cell injections for knee osteoarthritis: meta-analysis of RCTs (2025)
- NBA orthobiologics consensus statement (2020)
- FDA: Consumer alert on regenerative medicine products
- ISSCR: A patient’s guide to stem cell treatments
Related reading: Knee Pain Therapy Medellin · Is Stem Cell Therapy Legal in Colombia? · Types of Stem Cells and Where They Come From
Medically reviewed by Dr. Catalina Henao, MD. Last reviewed October 2026. This article is for general information and does not replace a medical consultation.
Explore Our Regenerative Treatments in Medellin
- Stem Cells in Colombia: 2026 Guide for International Patients
- Stem Cell Therapy Prices by Dose
- Knee Pain Stem Cell Therapy
- Joint Pain Stem Cell Therapy
- Back Pain Stem Cell Therapy
- Shoulder & Rotator Cuff Stem Cell Therapy
- Hip Pain Stem Cell Therapy
- Sports Injury Stem Cell Therapy
- Longevity & Anti-Aging Therapy
- Meet Dr. Catalina Henao

